These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 17046209

  • 21. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A, Aguilar L, Robledo O, Giménez MJ, Tarragó D, Granizo JJ, Gimeno M, Coronel P.
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [Abstract] [Full Text] [Related]

  • 22. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections.
    Varon E, Levy C, De La Rocque F, Boucherat M, Deforche D, Podglajen I, Navel M, Cohen R.
    Clin Infect Dis; 2000 Aug; 31(2):477-81. PubMed ID: 10987708
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
    Beekmann SE, Heilmann KP, Richter SS, García-de-Lomas J, Doern GV, GRASP Study Group.
    Int J Antimicrob Agents; 2005 Feb; 25(2):148-56. PubMed ID: 15664485
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Alexander Project--5 years in Poland].
    Hryniewicz W.
    Pol Merkur Lekarski; 2003 Jan; 14(79):5-8. PubMed ID: 12712818
    [Abstract] [Full Text] [Related]

  • 29. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C, Suárez L, Rubio-Calvo C, Gómez-Lus R, Gimeno M, Coronel P, Durán E, Becerril R, Oca M, Castillo FJ.
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Antimicrobial susceptibilities and analysis of genes related to penicillin or macrolide resistance in Streptococcus pneumoniae.
    Hiramatsu K, Ohama M, Mijajima Y, Kishi K, Mizunoe S, Tokimatsu I, Nagai H, Kadota J, Saikawa T, Nasu M.
    Int J Antimicrob Agents; 2004 Aug; 24(2):125-9. PubMed ID: 15288310
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Characterisation of a collection of Streptococcus pneumoniae isolates from patients suffering from acute exacerbations of chronic bronchitis: in vitro susceptibility to antibiotics and biofilm formation in relation to antibiotic efflux and serotypes/serogroups.
    Vandevelde NM, Tulkens PM, Diaz Iglesias Y, Verhaegen J, Rodriguez-Villalobos H, Philippart I, Cadrobbi J, Coppens N, Boel A, Van Vaerenbergh K, Francart H, Vanhoof R, Liistro G, Jordens P, d'Odemont JP, Valcke Y, Verschuren F, Van Bambeke F.
    Int J Antimicrob Agents; 2014 Sep; 44(3):209-17. PubMed ID: 25123808
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
    Sethi S, Breton J, Wynne B.
    Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
    [Abstract] [Full Text] [Related]

  • 38. Macrolide resistance rates in respiratory pathogens in Slovenia following reduced macrolide use.
    Cizman M, Beović B, Seme K, Paragi M, Strumbelj I, Müller-Premru M, Cad-Pecar S, Pokorn M.
    Int J Antimicrob Agents; 2006 Dec; 28(6):537-42. PubMed ID: 17101264
    [Abstract] [Full Text] [Related]

  • 39. Impact of antibiotics on pathogens associated with otitis media with effusion.
    Hamamoto Y, Gotoh Y, Nakajo Y, Shimoya S, Kayama C, Hasegawa S, Nibu K.
    J Laryngol Otol; 2005 Nov; 119(11):862-5. PubMed ID: 16354337
    [Abstract] [Full Text] [Related]

  • 40. Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis.
    Sethi S, Anzueto A, Farrell DJ.
    Ann Clin Microbiol Antimicrob; 2005 Mar 08; 4():5. PubMed ID: 15755326
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.